Inventor · disambiguated record
Stephen John Oliver
Also filed as: OLIVER STEPHEN · OLIVER STEPHEN JOHN
1 granted patent·9 pending applications·0 citations·filing 2013–2024
14Inventor score
Top patents by PatentIndex Score
10 records- 0174US2024425617A1Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such antibodiesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0263US11987644B2Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such antibodiesNOVARTIS AG·Filed 2020·Granted May 21, 2024·0 cites·4 claims
- 0355US2024239911A1Treatment for lupus nephritis using anti-baffr antibodiesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0455US2024228644A1Treatment for systemic lupus erythematosus using anti-baffr antibodiesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0549US2019002589A1Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such antibodiesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 0647US2022177570A1Use of the il-1beta binding antibody canakinumab for treating or alleviating symptoms of pulmonary sarcoidosisNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0746US2022356261A1Treatment for sjögren's syndromeNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0845US2023020548A1Anti-interleukin 1 beta antibodies for treatment of sickle cell diseaseNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0937US2015216867A1Compounds for use in gastric complicationCHRIST ANDREAS·Filed 2013·Application pending·0 cites
- 1033US2021292404A1Use of il-1beta binding antibody canakinumab for treating or allevating symptoms pulmonary sarcoidosisNOVARTIS AG·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephen John Oliver files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →